Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune ...

Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...

New Memorial Sloan Kettering Cancer Center research reveals how dormant metastatic cancer cells protect themselves from the ...

During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...

DelveInsight’s Metastatic Castration-Resistant Prostate Cancer pipeline report depicts a robust space with 75+ active players working to develop 75+ pipeline therapies for Metastatic ...

Kanazawa University, in collaboration with Osaka University and the National Institutes for Quantum Science and Technology, ...

Enhanced chemosensitivity: Laboratory data suggest PRP makes resistant pancreatic tumor cells more responsive to standard chemotherapies and alters the tumor microenvironment — including reduced ...

Metastasis-directed stereotactic radiotherapy alongside biological cancer therapy appears safe, new data show.

Brazilian research shows that stellate pancreatic cells produce periostin, remodeling tissue and facilitating tumor infiltration, a key mechanism of the aggressiveness and high mortality of the ...

The anti-tumor immune response involves a series of complex steps mediated by various immune cells and signaling molecules.

Discover a comprehensive palliative care plan designed to enhance quality of life for those with metastatic bladder cancer.

Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.